🇺🇸 FDA
Patent

US 7183389

Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)

granted A61KA61K2039/505A61P

Quick answer

US patent 7183389 (Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)) held by Molecular Discoveries, Inc. expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Molecular Discoveries, Inc.
Grant date
Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/505, A61P, A61P11/00, A61P35/00